Top Markets
Coin of the day
OptiBiotix Health Plc OptiBiotix Health Plc

OptiBiotix Health Plc

OPTI
Rangering i aksjer #40732
OptiBiotix Health Plc, a life sciences enterprise headquartered in York, United... OptiBiotix Health Plc, a life sciences enterprise headquartered in York, United Kingdom, specializes in the discovery and advancement of microbiome-modulating technologies. The company formulates distinct microbial strains, innovative compounds, and tailored blends intended for integration into food products, nutritional supplements, and active ingredients. Their groundbreaking work aims to positively influence human physiology and yield substantial health benefits. Among its diverse product portfolio are Slimbiome, a natural ingredient for healthy and satiety-driven weight management, and SlimBiome Medical, a supplemental aid for weight control. Other offerings include CholBiome, a dietary supplement for maintaining healthy cholesterol; Lactobacillus plantarum LPLDL, a probiotic supporting cardiovascular health and overall well-being; LPGOS, a galactooligosaccharide utilized in food applications to mitigate cardiovascular risk factors and enhance general health; WellBiome, a functional fiber and mineral blend designed to bolster gut microbiome diversity and promote wellness; and Sweetbiotix, a sweetener for use in various foods and beverages. Ultimately, OptiBiotix's innovations are designed to prevent and manage prevalent chronic lifestyle diseases, including obesity, high cholesterol, and diabetes. The company was founded in 2012.
Aksjekurs
$0.07994122
Sist synkronisert: 2026-09-25
Markedsverdi
$82.58K
Endring (1 dag)
0.43%
Endring (1 år)
-44.51%
Land
GB
Handel OptiBiotix Health Plc (OPTI)

Kategori

P/E-forhold for OptiBiotix Health Plc (OPTI)
P/E-forhold per September 2026 TTM: -1.68
Ifølge OptiBiotix Health Plc sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/E-forhold (TTM) -1.68. Ved slutten av 2023 hadde selskapet en P/E på -11.83.
P/E-forholdshistorikk for OptiBiotix Health Plc fra 2007 til 2026
P/E-forhold ved slutten av hvert år
År P/E-forhold Endre
2026 (TTM) -1.68 -82.79%
2024 -9.76 -17.49%
2023 -11.83 -361.69%
2022 4.52 -29.73%
2021 6.43 -26.20%
2020 8.72 -136.69%
2019 -23.76 -40.69%
2018 -40.07 -226.08%
2017 31.78 -181.69%
2016 -38.90 -20.80%
2015 -49.12 569.27%
2014 -7.34 10,805.65%
2013 -0.07 -82.62%
2012 -0.39 -91.53%
2011 -4.57 -40.81%
2010 -7.72 -55.56%
2009 -17.38 100.00%
2008 -8.69 32.15%
2007 -6.58 0.00%
P/E-forhold for lignende selskaper eller konkurrenter
Selskap P/E-forhold Forskjell i P/E-forhold Land
29.99 -1,885.51%
US
-18.38 994.24%
US
36.30 -2,260.57%
NL
-23.34 1,289.20%
AU
- -
CH
Hvordan lese en P/E-ratio?

Pris/inntjening-forholdet (P/E) måler forholdet mellom aksjekursen og inntjening per aksje.
En lav men positiv P/E indikerer høy inntjening sammenlignet med nåværende verdsettelse, og kan tyde på at selskapet er undervurdert. En høy negativ (nær 0) P/E indikerer store tap.

Selskaper med P/E over 30 eller negativ betraktes vanligvis som "vekstaksjer", hvor investorer forventer vekst eller fremtidig lønnsomhet.

Selskaper med en positiv P/E under 10 anses vanligvis som "verdiaksjer", det vil si at selskapet allerede er lønnsomt, men har begrenset vekstpotensial.